What We Do
Oyster provides hands-on support for early to mid-stage life science and healthcare companies with preparation and execution of their investment raising strategies. We support our clients with investor-ready business planning, collateral development, pre-qualified investor matching, direct introductions, transaction development and deal process support.
We support companies across the globe with raising their Seed to Series-A/B investments, whilst guiding businesses with strategies to maximise exit investment returns. Oyster is a investment advisor for the UK Department for International Trade, supporting their prospective FDI clients from all over the world with investment to enable their foreign direct investment in the UK.
Our Services
‘No second chance to make
a great first impression.’
For entrepreneurs and their
world-class technologies,
Oyster maximises investment opportunities by ensuring collateral is at an
investor-ready standard.
‘The only impossible journey
is the one never begun.’
Oyster identifies, qualifies
and introduces novel
technology companies to
Seed to Series-A/B
investors across
the globe.
‘Neither one of us is more
capable than all of us.’
From investor engagement
to transaction development
to due diligence and deal
closure, Oyster actively supports its clients
end-to-end.
Our Focus
Our Focus
- Digital Health
- Drug Discovery
- Life Science
- Therapeutics
- Healthcare
- Medical Technology
- Diagnostics
- Biotechnology
Our Approach
In-depth business strategy, scientific roadmap
and collateral review to
optimise investment
propositions.
Investor ready collateral
creation, ensuring investor
due diligence is assessed
ahead of a discussion.
Technology and investor
matching against 10,000+ global life science /
healthcare investor base.
Digital marketing delivering
real-time analytics to enable decision support on a range of campaign strategies.
Support through the legal
and due diligence process,
term sheet review and deal
closures support.
Post-deal mobilisation management, strategy road mapping and next phase investment support.
In-depth business strategy, scientific roadmap
and collateral review to
optimise investment
propositions.
Investor ready collateral
creation, ensuring investor
due diligence is assessed
ahead of a discussion.
Technology and investor matching against 10,000+ global
life science / healthcare
investor base.
Digital marketing delivering
real-time analytics
to enable decision support on a
range of campaign strategies.
Support through the legal
and due diligence process,
term sheet review and deal
closures support.
Post-deal mobilisation
management, strategy road
mapping and next phase
investment support.